NIKI Stock Summary and Trading Ideas (Niki Biosolutions | NASDAQ:NIKI)

Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).

What symbol and exchange does Niki Biosolutions shares trade?

Niki Biosolutions trades on the NASDAQ stock market under the symbol NIKI.

What is Niki Biosolutions stock price doing today?

As of September 23, 2026, NIKI stock price declined to $4.68 with 5,501 million shares trading.

How much is Niki Biosolutions worth?

NIKI has a market cap of $3.81 million. This is considered a Sub-Micro Cap stock.

What are the support and resistance levels for Niki Biosolutions (NIKI)?

NIKI support price is $4.43 and resistance is $5.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NIKI shares will trade within this expected range on the day.